Maslimomab

From WikiMD.org
Jump to navigation Jump to search

Maslimomab

Maslimomab (pronunciation: mas-li-MO-mab) is a type of monoclonal antibody used in the treatment of certain medical conditions.

Etymology

The name "Maslimomab" is derived from the International Nonproprietary Names (INN), where "mab" stands for monoclonal antibody. The prefix "Masli" does not have a specific meaning and is used to create a unique name.

Usage

Maslimomab is used in the treatment of cancer, specifically leukemia and lymphoma. It works by targeting specific proteins on the surface of cancer cells, thereby helping the immune system to destroy these cells.

Related Terms

  • Monoclonal antibody: A type of protein made in the laboratory that can bind to substances in the body, including cancer cells.
  • Leukemia: A type of cancer of the blood cells in which the white blood cells (leukocytes) are overproduced.
  • Lymphoma: A type of cancer that begins in the lymphatic system, the body's disease-fighting network.

Side Effects

Like all medications, Maslimomab can cause side effects. Common side effects include fever, chills, nausea, and fatigue. More serious side effects can include allergic reactions, heart problems, and lung problems.

Precautions

Before starting treatment with Maslimomab, patients should discuss their medical history with their healthcare provider, including any allergies, heart problems, lung problems, or other medical conditions.

External links

Esculaap.svg

This WikiMD dictionary article is a stub. You can help make it a full article.


Languages: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, Urdu, বাংলা, తెలుగు, தமிழ், ಕನ್ನಡ,
Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, European español, Deutsch, français, русский, português do Brasil, Italian, polski